View Financial HealthNanjing Red SunLtd 배당 및 자사주 매입배당 기준 점검 0/6Nanjing Red SunLtd 현재 배당금을 지급하지 않습니다.핵심 정보0%배당 수익률n/a자사주 매입 수익률총 주주 수익률n/a미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향0%최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updates공고 • Jun 30Nanjing Red Sun Co.,Ltd. to Report First Half, 2026 Results on Aug 18, 2026Nanjing Red Sun Co.,Ltd. announced that they will report first half, 2026 results on Aug 18, 2026Board Change • May 20High number of new and inexperienced directorsThere are 10 new directors who have joined the board in the last 3 years. The company's board is composed of: 10 new directors. 2 experienced directors. No highly experienced directors. Employee Representative Supervisor Xiaosheng Yang is the most experienced director on the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.공고 • Apr 28Nanjing Red Sun Co.,Ltd., Annual General Meeting, May 28, 2026Nanjing Red Sun Co.,Ltd., Annual General Meeting, May 28, 2026, at 15:00 China Standard Time. Location: The Company's Meeting Room, Nanjing, Jiangsu China공고 • Mar 31Nanjing Red Sun Co.,Ltd. to Report Q1, 2026 Results on Apr 28, 2026Nanjing Red Sun Co.,Ltd. announced that they will report Q1, 2026 results on Apr 28, 2026공고 • Dec 31Nanjing Red Sun Co.,Ltd. to Report Fiscal Year 2025 Results on Apr 28, 2026Nanjing Red Sun Co.,Ltd. announced that they will report fiscal year 2025 results on Apr 28, 2026공고 • Sep 30Nanjing Red Sun Co.,Ltd. to Report Q3, 2025 Results on Oct 30, 2025Nanjing Red Sun Co.,Ltd. announced that they will report Q3, 2025 results on Oct 30, 2025공고 • Jul 02Nanjing Red Sun Co.,Ltd. to Report First Half, 2025 Results on Aug 29, 2025Nanjing Red Sun Co.,Ltd. announced that they will report first half, 2025 results on Aug 29, 2025공고 • Apr 26Nanjing Red Sun Co.,Ltd., Annual General Meeting, May 28, 2025Nanjing Red Sun Co.,Ltd., Annual General Meeting, May 28, 2025, at 15:00 China Standard Time. Location: The Company's Meeting Room, Nanjing, Jiangsu China공고 • Mar 31Nanjing Red Sun Co.,Ltd. to Report Q1, 2025 Results on Apr 26, 2025Nanjing Red Sun Co.,Ltd. announced that they will report Q1, 2025 results on Apr 26, 2025공고 • Dec 31Nanjing Red Sun Co.,Ltd. to Report Fiscal Year 2024 Results on Apr 26, 2025Nanjing Red Sun Co.,Ltd. announced that they will report fiscal year 2024 results on Apr 26, 2025공고 • Dec 29Nanjing Red Sun Co.,Ltd. Approves Management ElectionsNanjing Red Sun Co.,Ltd. at its Extraordinary General Meeting held on 25 December 2024, approved the election of Yang Yi, Hu Rongmao, Bao Qiongzao, Zhang Libing, Yang Bin and Cheng Yuan as non-independent director. The company approved the election of Mu Peilin and Wei Zhongxiong as independent director. The company approved the election of Fu Xuyao, Tao Biao and Zhou Zijun as shareholder supervisor.Reported Earnings • Oct 31Third quarter 2024 earnings released: EPS: CN¥0.01 (vs CN¥0.009 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.01 (up from CN¥0.009 in 3Q 2023). Revenue: CN¥1.06b (flat on 3Q 2023). Net income: CN¥5.52m (up 1.5% from 3Q 2023). Profit margin: 0.5% (in line with 3Q 2023). Over the last 3 years on average, earnings per share has increased by 71% per year but the company’s share price has only increased by 21% per year, which means it is significantly lagging earnings growth.Reported Earnings • Aug 31Second quarter 2024 earnings released: EPS: CN¥0.002 (vs CN¥0.012 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.002 (down from CN¥0.012 in 2Q 2023). Revenue: CN¥796.7m (down 6.8% from 2Q 2023). Net income: CN¥1.16m (down 83% from 2Q 2023). Profit margin: 0.1% (down from 0.8% in 2Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 55% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth.New Risk • Jul 18New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 20% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (7.5% average weekly change).공고 • Jun 29Nanjing Red Sun Co.,Ltd. to Report First Half, 2024 Results on Aug 31, 2024Nanjing Red Sun Co.,Ltd. announced that they will report first half, 2024 results on Aug 31, 2024Reported Earnings • May 01First quarter 2024 earnings released: EPS: CN¥0.035 (vs CN¥0.02 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.035 (up from CN¥0.02 in 1Q 2023). Revenue: CN¥845.7m (up 13% from 1Q 2023). Net income: CN¥20.1m (up 77% from 1Q 2023). Profit margin: 2.4% (up from 1.5% in 1Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has only increased by 18% per year, which means it is significantly lagging earnings growth.공고 • May 01Nanjing Red Sun Co.,Ltd., Annual General Meeting, Jun 27, 2024Nanjing Red Sun Co.,Ltd., Annual General Meeting, Jun 27, 2024, at 14:30 China Standard Time. Location: The Company's Meeting Room, Nanjing, Jiangsu China공고 • Mar 30Nanjing Red Sun Co.,Ltd. to Report Q1, 2024 Results on Apr 30, 2024Nanjing Red Sun Co.,Ltd. announced that they will report Q1, 2024 results on Apr 30, 2024공고 • Dec 30Nanjing Red Sun Co.,Ltd. to Report Fiscal Year 2023 Results on Apr 30, 2024Nanjing Red Sun Co.,Ltd. announced that they will report fiscal year 2023 results on Apr 30, 2024Reported Earnings • Nov 02Third quarter 2023 earnings released: EPS: CN¥0.009 (vs CN¥0.57 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.009 (down from CN¥0.57 in 3Q 2022). Revenue: CN¥1.05b (down 45% from 3Q 2022). Net income: CN¥5.43m (down 98% from 3Q 2022). Profit margin: 0.5% (down from 17% in 3Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 7% per year and the company’s share price has also increased by 7% per year.Valuation Update With 7 Day Price Move • Oct 30Investor sentiment improves as stock rises 17%After last week's 17% share price gain to CN¥8.57, the stock trades at a trailing P/E ratio of 37.4x. Average trailing P/E is 34x in the Chemicals industry in China. Total returns to shareholders of 22% over the past three years.New Risk • Sep 11New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 2.1x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.1x net interest cover). Minor Risk Large one-off items impacting financial results.Reported Earnings • Aug 30Second quarter 2023 earnings released: EPS: CN¥0.012 (vs CN¥0.53 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.012 (down from CN¥0.53 in 2Q 2022). Revenue: CN¥855.1m (down 56% from 2Q 2022). Net income: CN¥6.70m (down 98% from 2Q 2022). Profit margin: 0.8% (down from 16% in 2Q 2022). Over the last 3 years on average, earnings per share has fallen by 9% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings.공고 • Jun 02Nanjing Red Sun Co.,Ltd., Annual General Meeting, Jun 21, 2023Nanjing Red Sun Co.,Ltd., Annual General Meeting, Jun 21, 2023, at 14:30 China Standard Time. Agenda: To consider 2022 work report of the board of directors; to consider 2022 work report of the supervisory committee; to consider 2022 annual report and its summary; to consider 2022 annual accounts; to consider 2022 profit distribution plan; to consider Reappointment of 2023 audit firm; to consider 2022 remuneration for directors, supervisors and senior management; to consider Shareholder return plan for the next three years from 2023 to 2025; and to consider other business matters.Valuation Update With 7 Day Price Move • May 25Investor sentiment improves as stock rises 18%After last week's 18% share price gain to CN¥8.27, the stock trades at a trailing P/E ratio of 11x. Average trailing P/E is 30x in the Chemicals industry in China. Total loss to shareholders of 6.4% over the past three years.Valuation Update With 7 Day Price Move • May 10Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to CN¥7.09, the stock trades at a trailing P/E ratio of 9.4x. Average trailing P/E is 29x in the Chemicals industry in China. Total loss to shareholders of 22% over the past three years.Reported Earnings • Apr 29Full year 2022 earnings released: EPS: CN¥1.26 (vs CN¥6.45 loss in FY 2021)Full year 2022 results: EPS: CN¥1.26 (up from CN¥6.45 loss in FY 2021). Revenue: CN¥6.44b (up 38% from FY 2021). Net income: CN¥732.3m (up CN¥4.48b from FY 2021). Profit margin: 11% (up from net loss in FY 2021). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 56% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings.Board Change • Nov 16High number of new and inexperienced directorsThere are 8 new directors who have joined the board in the last 3 years. The company's board is composed of: 8 new directors. 4 experienced directors. No highly experienced directors. Independent Director Zhen Yan is the most experienced director on the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Reported Earnings • Oct 31Third quarter 2022 earnings released: EPS: CN¥0.57 (vs CN¥0.009 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.57 (up from CN¥0.009 in 3Q 2021). Revenue: CN¥1.90b (up 77% from 3Q 2021). Net income: CN¥328.5m (up CN¥322.7m from 3Q 2021). Profit margin: 17% (up from 0.5% in 3Q 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 106 percentage points per year, which is a significant difference in performance.Reported Earnings • Sep 02Second quarter 2022 earnings released: EPS: CN¥0.53 (vs CN¥0.014 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.53 (up from CN¥0.014 in 2Q 2021). Revenue: CN¥1.95b (up 77% from 2Q 2021). Net income: CN¥311.6m (up CN¥303.2m from 2Q 2021). Profit margin: 16% (up from 0.8% in 2Q 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 123 percentage points per year, which is a significant difference in performance.Reported Earnings • May 02First quarter 2022 earnings released: EPS: CN¥0.53 (vs CN¥0.038 in 1Q 2021)First quarter 2022 results: EPS: CN¥0.53 (up from CN¥0.038 in 1Q 2021). Revenue: CN¥1.53b (up 78% from 1Q 2021). Net income: CN¥305.6m (up CN¥283.5m from 1Q 2021). Profit margin: 20% (up from 2.6% in 1Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 111 percentage points per year, which is a significant difference in performance.Board Change • Apr 27High number of new and inexperienced directorsThere are 8 new directors who have joined the board in the last 3 years. The company's board is composed of: 8 new directors. 4 experienced directors. No highly experienced directors. Independent Director Zhen Yan is the most experienced director on the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Reported Earnings • Apr 10Full year 2021 earnings released: CN¥6.42 loss per share (vs CN¥0.27 loss in FY 2020)Full year 2021 results: CN¥6.42 loss per share (down from CN¥0.27 loss in FY 2020). Revenue: CN¥4.68b (up 16% from FY 2020). Net loss: CN¥3.73b (loss widened CN¥3.57b from FY 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 99 percentage points per year, which is a significant difference in performance.Reported Earnings • Sep 01Second quarter 2021 earnings released: EPS CN¥0.014 (vs CN¥0.10 in 2Q 2020)The company reported a poor second quarter result with weaker earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥1.10b (down 13% from 2Q 2020). Net income: CN¥8.41m (down 86% from 2Q 2020). Profit margin: 0.8% (down from 4.7% in 2Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 62 percentage points per year, which is a significant difference in performance.Reported Earnings • Apr 17Full year 2020 earnings released: CN¥0.24 loss per share (vs CN¥0.59 loss in FY 2019)The company reported a decent full year result with reduced losses and improved control over expenses, although revenues were weaker. Full year 2020 results: Revenue: CN¥4.08b (down 12% from FY 2019). Net loss: CN¥140.7m (loss narrowed 59% from FY 2019). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 56 percentage points per year, which is a significant difference in performance.Is New 90 Day High Low • Feb 04New 90-day low: CN¥5.30The company is down 25% from its price of CN¥7.08 on 06 November 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 20% over the same period.Is New 90 Day High Low • Jan 13New 90-day low: CN¥5.34The company is down 28% from its price of CN¥7.38 on 16 October 2020. The Chinese market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 11% over the same period.Is New 90 Day High Low • Dec 28New 90-day low: CN¥6.04The company is down 13% from its price of CN¥6.91 on 30 September 2020. The Chinese market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 14% over the same period.Is New 90 Day High Low • Dec 09New 90-day low: CN¥6.80The company is down 12% from its price of CN¥7.71 on 11 September 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 10.0% over the same period.Reported Earnings • Oct 30Third quarter earnings releasedOver the last 12 months the company has reported total losses of CN¥535.5m, with earnings decreasing by CN¥895.4m from the prior year. Total revenue was CN¥3.48b over the last 12 months, down 40% from the prior year.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 000525 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: 000525 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장Nanjing Red SunLtd 배당 수익률 vs 시장000525의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (000525)0%시장 하위 25% (CN)0.4%시장 상위 25% (CN)2.2%업계 평균 (Chemicals)1.4%분석가 예측 (000525) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 000525 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 000525 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: 000525 CN 시장에서 주목할만한 배당금을 지급하지 않습니다.주주 현금 배당현금 흐름 범위: 000525 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YCN 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/08/24 07:44종가2026/08/21 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Nanjing Red Sun Co.,Ltd.는 5명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Zheng GaoChina International Capital Corporation LimitedWei MaoEverbright Securities Co. Ltd.Shi JiHuatai Research2명의 분석가 더 보기
공고 • Jun 30Nanjing Red Sun Co.,Ltd. to Report First Half, 2026 Results on Aug 18, 2026Nanjing Red Sun Co.,Ltd. announced that they will report first half, 2026 results on Aug 18, 2026
Board Change • May 20High number of new and inexperienced directorsThere are 10 new directors who have joined the board in the last 3 years. The company's board is composed of: 10 new directors. 2 experienced directors. No highly experienced directors. Employee Representative Supervisor Xiaosheng Yang is the most experienced director on the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
공고 • Apr 28Nanjing Red Sun Co.,Ltd., Annual General Meeting, May 28, 2026Nanjing Red Sun Co.,Ltd., Annual General Meeting, May 28, 2026, at 15:00 China Standard Time. Location: The Company's Meeting Room, Nanjing, Jiangsu China
공고 • Mar 31Nanjing Red Sun Co.,Ltd. to Report Q1, 2026 Results on Apr 28, 2026Nanjing Red Sun Co.,Ltd. announced that they will report Q1, 2026 results on Apr 28, 2026
공고 • Dec 31Nanjing Red Sun Co.,Ltd. to Report Fiscal Year 2025 Results on Apr 28, 2026Nanjing Red Sun Co.,Ltd. announced that they will report fiscal year 2025 results on Apr 28, 2026
공고 • Sep 30Nanjing Red Sun Co.,Ltd. to Report Q3, 2025 Results on Oct 30, 2025Nanjing Red Sun Co.,Ltd. announced that they will report Q3, 2025 results on Oct 30, 2025
공고 • Jul 02Nanjing Red Sun Co.,Ltd. to Report First Half, 2025 Results on Aug 29, 2025Nanjing Red Sun Co.,Ltd. announced that they will report first half, 2025 results on Aug 29, 2025
공고 • Apr 26Nanjing Red Sun Co.,Ltd., Annual General Meeting, May 28, 2025Nanjing Red Sun Co.,Ltd., Annual General Meeting, May 28, 2025, at 15:00 China Standard Time. Location: The Company's Meeting Room, Nanjing, Jiangsu China
공고 • Mar 31Nanjing Red Sun Co.,Ltd. to Report Q1, 2025 Results on Apr 26, 2025Nanjing Red Sun Co.,Ltd. announced that they will report Q1, 2025 results on Apr 26, 2025
공고 • Dec 31Nanjing Red Sun Co.,Ltd. to Report Fiscal Year 2024 Results on Apr 26, 2025Nanjing Red Sun Co.,Ltd. announced that they will report fiscal year 2024 results on Apr 26, 2025
공고 • Dec 29Nanjing Red Sun Co.,Ltd. Approves Management ElectionsNanjing Red Sun Co.,Ltd. at its Extraordinary General Meeting held on 25 December 2024, approved the election of Yang Yi, Hu Rongmao, Bao Qiongzao, Zhang Libing, Yang Bin and Cheng Yuan as non-independent director. The company approved the election of Mu Peilin and Wei Zhongxiong as independent director. The company approved the election of Fu Xuyao, Tao Biao and Zhou Zijun as shareholder supervisor.
Reported Earnings • Oct 31Third quarter 2024 earnings released: EPS: CN¥0.01 (vs CN¥0.009 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.01 (up from CN¥0.009 in 3Q 2023). Revenue: CN¥1.06b (flat on 3Q 2023). Net income: CN¥5.52m (up 1.5% from 3Q 2023). Profit margin: 0.5% (in line with 3Q 2023). Over the last 3 years on average, earnings per share has increased by 71% per year but the company’s share price has only increased by 21% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Aug 31Second quarter 2024 earnings released: EPS: CN¥0.002 (vs CN¥0.012 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.002 (down from CN¥0.012 in 2Q 2023). Revenue: CN¥796.7m (down 6.8% from 2Q 2023). Net income: CN¥1.16m (down 83% from 2Q 2023). Profit margin: 0.1% (down from 0.8% in 2Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 55% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth.
New Risk • Jul 18New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 20% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (7.5% average weekly change).
공고 • Jun 29Nanjing Red Sun Co.,Ltd. to Report First Half, 2024 Results on Aug 31, 2024Nanjing Red Sun Co.,Ltd. announced that they will report first half, 2024 results on Aug 31, 2024
Reported Earnings • May 01First quarter 2024 earnings released: EPS: CN¥0.035 (vs CN¥0.02 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.035 (up from CN¥0.02 in 1Q 2023). Revenue: CN¥845.7m (up 13% from 1Q 2023). Net income: CN¥20.1m (up 77% from 1Q 2023). Profit margin: 2.4% (up from 1.5% in 1Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has only increased by 18% per year, which means it is significantly lagging earnings growth.
공고 • May 01Nanjing Red Sun Co.,Ltd., Annual General Meeting, Jun 27, 2024Nanjing Red Sun Co.,Ltd., Annual General Meeting, Jun 27, 2024, at 14:30 China Standard Time. Location: The Company's Meeting Room, Nanjing, Jiangsu China
공고 • Mar 30Nanjing Red Sun Co.,Ltd. to Report Q1, 2024 Results on Apr 30, 2024Nanjing Red Sun Co.,Ltd. announced that they will report Q1, 2024 results on Apr 30, 2024
공고 • Dec 30Nanjing Red Sun Co.,Ltd. to Report Fiscal Year 2023 Results on Apr 30, 2024Nanjing Red Sun Co.,Ltd. announced that they will report fiscal year 2023 results on Apr 30, 2024
Reported Earnings • Nov 02Third quarter 2023 earnings released: EPS: CN¥0.009 (vs CN¥0.57 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.009 (down from CN¥0.57 in 3Q 2022). Revenue: CN¥1.05b (down 45% from 3Q 2022). Net income: CN¥5.43m (down 98% from 3Q 2022). Profit margin: 0.5% (down from 17% in 3Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 7% per year and the company’s share price has also increased by 7% per year.
Valuation Update With 7 Day Price Move • Oct 30Investor sentiment improves as stock rises 17%After last week's 17% share price gain to CN¥8.57, the stock trades at a trailing P/E ratio of 37.4x. Average trailing P/E is 34x in the Chemicals industry in China. Total returns to shareholders of 22% over the past three years.
New Risk • Sep 11New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 2.1x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.1x net interest cover). Minor Risk Large one-off items impacting financial results.
Reported Earnings • Aug 30Second quarter 2023 earnings released: EPS: CN¥0.012 (vs CN¥0.53 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.012 (down from CN¥0.53 in 2Q 2022). Revenue: CN¥855.1m (down 56% from 2Q 2022). Net income: CN¥6.70m (down 98% from 2Q 2022). Profit margin: 0.8% (down from 16% in 2Q 2022). Over the last 3 years on average, earnings per share has fallen by 9% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings.
공고 • Jun 02Nanjing Red Sun Co.,Ltd., Annual General Meeting, Jun 21, 2023Nanjing Red Sun Co.,Ltd., Annual General Meeting, Jun 21, 2023, at 14:30 China Standard Time. Agenda: To consider 2022 work report of the board of directors; to consider 2022 work report of the supervisory committee; to consider 2022 annual report and its summary; to consider 2022 annual accounts; to consider 2022 profit distribution plan; to consider Reappointment of 2023 audit firm; to consider 2022 remuneration for directors, supervisors and senior management; to consider Shareholder return plan for the next three years from 2023 to 2025; and to consider other business matters.
Valuation Update With 7 Day Price Move • May 25Investor sentiment improves as stock rises 18%After last week's 18% share price gain to CN¥8.27, the stock trades at a trailing P/E ratio of 11x. Average trailing P/E is 30x in the Chemicals industry in China. Total loss to shareholders of 6.4% over the past three years.
Valuation Update With 7 Day Price Move • May 10Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to CN¥7.09, the stock trades at a trailing P/E ratio of 9.4x. Average trailing P/E is 29x in the Chemicals industry in China. Total loss to shareholders of 22% over the past three years.
Reported Earnings • Apr 29Full year 2022 earnings released: EPS: CN¥1.26 (vs CN¥6.45 loss in FY 2021)Full year 2022 results: EPS: CN¥1.26 (up from CN¥6.45 loss in FY 2021). Revenue: CN¥6.44b (up 38% from FY 2021). Net income: CN¥732.3m (up CN¥4.48b from FY 2021). Profit margin: 11% (up from net loss in FY 2021). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 56% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings.
Board Change • Nov 16High number of new and inexperienced directorsThere are 8 new directors who have joined the board in the last 3 years. The company's board is composed of: 8 new directors. 4 experienced directors. No highly experienced directors. Independent Director Zhen Yan is the most experienced director on the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Reported Earnings • Oct 31Third quarter 2022 earnings released: EPS: CN¥0.57 (vs CN¥0.009 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.57 (up from CN¥0.009 in 3Q 2021). Revenue: CN¥1.90b (up 77% from 3Q 2021). Net income: CN¥328.5m (up CN¥322.7m from 3Q 2021). Profit margin: 17% (up from 0.5% in 3Q 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 106 percentage points per year, which is a significant difference in performance.
Reported Earnings • Sep 02Second quarter 2022 earnings released: EPS: CN¥0.53 (vs CN¥0.014 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.53 (up from CN¥0.014 in 2Q 2021). Revenue: CN¥1.95b (up 77% from 2Q 2021). Net income: CN¥311.6m (up CN¥303.2m from 2Q 2021). Profit margin: 16% (up from 0.8% in 2Q 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 123 percentage points per year, which is a significant difference in performance.
Reported Earnings • May 02First quarter 2022 earnings released: EPS: CN¥0.53 (vs CN¥0.038 in 1Q 2021)First quarter 2022 results: EPS: CN¥0.53 (up from CN¥0.038 in 1Q 2021). Revenue: CN¥1.53b (up 78% from 1Q 2021). Net income: CN¥305.6m (up CN¥283.5m from 1Q 2021). Profit margin: 20% (up from 2.6% in 1Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 111 percentage points per year, which is a significant difference in performance.
Board Change • Apr 27High number of new and inexperienced directorsThere are 8 new directors who have joined the board in the last 3 years. The company's board is composed of: 8 new directors. 4 experienced directors. No highly experienced directors. Independent Director Zhen Yan is the most experienced director on the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Reported Earnings • Apr 10Full year 2021 earnings released: CN¥6.42 loss per share (vs CN¥0.27 loss in FY 2020)Full year 2021 results: CN¥6.42 loss per share (down from CN¥0.27 loss in FY 2020). Revenue: CN¥4.68b (up 16% from FY 2020). Net loss: CN¥3.73b (loss widened CN¥3.57b from FY 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 99 percentage points per year, which is a significant difference in performance.
Reported Earnings • Sep 01Second quarter 2021 earnings released: EPS CN¥0.014 (vs CN¥0.10 in 2Q 2020)The company reported a poor second quarter result with weaker earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥1.10b (down 13% from 2Q 2020). Net income: CN¥8.41m (down 86% from 2Q 2020). Profit margin: 0.8% (down from 4.7% in 2Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 62 percentage points per year, which is a significant difference in performance.
Reported Earnings • Apr 17Full year 2020 earnings released: CN¥0.24 loss per share (vs CN¥0.59 loss in FY 2019)The company reported a decent full year result with reduced losses and improved control over expenses, although revenues were weaker. Full year 2020 results: Revenue: CN¥4.08b (down 12% from FY 2019). Net loss: CN¥140.7m (loss narrowed 59% from FY 2019). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 56 percentage points per year, which is a significant difference in performance.
Is New 90 Day High Low • Feb 04New 90-day low: CN¥5.30The company is down 25% from its price of CN¥7.08 on 06 November 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 20% over the same period.
Is New 90 Day High Low • Jan 13New 90-day low: CN¥5.34The company is down 28% from its price of CN¥7.38 on 16 October 2020. The Chinese market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 11% over the same period.
Is New 90 Day High Low • Dec 28New 90-day low: CN¥6.04The company is down 13% from its price of CN¥6.91 on 30 September 2020. The Chinese market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 14% over the same period.
Is New 90 Day High Low • Dec 09New 90-day low: CN¥6.80The company is down 12% from its price of CN¥7.71 on 11 September 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 10.0% over the same period.
Reported Earnings • Oct 30Third quarter earnings releasedOver the last 12 months the company has reported total losses of CN¥535.5m, with earnings decreasing by CN¥895.4m from the prior year. Total revenue was CN¥3.48b over the last 12 months, down 40% from the prior year.